Equities

CellSeed Inc

7776:TYO

CellSeed Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)785.00
  • Today's Change-14.00 / -1.75%
  • Shares traded7.43m
  • 1 Year change+91.46%
  • Beta0.9253
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,1631,072931
Total Receivables, Net1147194
Total Inventory465642
Prepaid expenses282224
Other current assets, total0.00114.40
Total current assets2,3521,2321,094
Property, plant & equipment, net098106
Goodwill, net------
Intangibles, net------
Long term investments2011998
Note receivable - long term------
Other long term assets949494
Total assets2,4661,5441,392
LIABILITIES
Accounts payable3.780.395.02
Accrued expenses14144.49
Notes payable/short-term debt000
Current portion long-term debt/capital leases7.507.501.25
Other current liabilities, total98159162
Total current liabilities124181173
Total long term debt144151159
Total debt151159160
Deferred income tax------
Minority interest------
Other liabilities, total343434
Total liabilities301366365
SHAREHOLDERS EQUITY
Common stock2,3841,4674,549
Additional paid-in capital1,3644471,770
Retained earnings (accumulated deficit)(1583)(735)(5291)
Treasury stock - common(0.23)(0.23)(0.23)
Unrealized gain (loss)--(0.32)(0.32)
Other equity, total0--(0.15)
Total equity2,1651,1781,027
Total liabilities & shareholders' equity2,4661,5441,392
Total common shares outstanding312418
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.